What are the best treatments for Multiple myeloma?

Multiple myeloma treatment is highly personalized, typically involving a combination of targeted therapies, immunomodulatory drugs, and proteasome inhibitors to manage the disease and prevent organ damage. For eligible patients, high-dose chemotherapy followed by an autologous stem cell transplant remains a gold standard, often preceded by "induction therapy" to reduce the tumor burden.

What are the current first-line treatments for Multiple myeloma?

First-line therapy for Multiple myeloma usually involves a triplet or quadruplet regimen. Physicians typically combine a proteasome inhibitor, an immunomodulatory drug, and a corticosteroid. Common medications include bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone. These frontline strategies aim to achieve deep remission, which is the most significant predictor of long-term survival in Multiple myeloma patients.

Which non-pharmacological interventions support care?

Managing the systemic effects of Multiple myeloma requires more than medication. Non-pharmacological approaches are vital for maintaining quality of life:

• Physical Therapy: To maintain mobility and strength, especially if bone lesions are present.


• Orthopedic Surgery: Often used to stabilize bones at high risk of fracture or to treat spinal cord compression.


• Radiation Therapy: Frequently utilized for targeted pain relief or to shrink localized tumors causing structural issues.


• Nutritional Counseling: To manage treatment-related side effects and support overall bone health.

What are the emerging treatments for Multiple myeloma?

The landscape for Multiple myeloma is rapidly evolving through clinical trials. Notable advancements include CAR T-cell therapy (such as idecabtagene vicleucel) and bispecific T-cell engagers (such as teclistamab). These therapies harness the patient's immune system to identify and destroy Multiple myeloma cells, offering new hope for individuals with relapsed or refractory disease.

Who should be on your multidisciplinary care team?

Treating Multiple myeloma requires a collaborative approach. Your team should ideally include a hematologist-oncologist specializing in plasma cell dyscrasias, an orthopedic surgeon, a radiation oncologist, a specialized nurse navigator, and a clinical psychologist to support the emotional challenges of chronic illness. At DiseaseMaps.org, 217 people with Multiple myeloma have shared their experiences, highlighting the importance of peer support alongside clinical care.

Next steps

• Consult a hematologist-oncologist to discuss your specific cytogenetic risk profile.


• Join the DiseaseMaps.org community to connect with others managing Multiple myeloma.


• Inquire about clinical trials through the NIH or local academic cancer centers.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your personal healthcare team for treatment decisions tailored to your specific clinical situation.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Multiple Myeloma Overview


• Orphanet: Rare Disease Database (ORPHA: 597)


• Multiple Myeloma Research Foundation (MMRF): Treatment Guidelines


• National Comprehensive Cancer Network (NCCN): Clinical Practice Guidelines in Oncology